Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
The Journal of Clinical Psychiatry|August 10, 2007
Levetiracetam as adjunctive therapy for refractory anxiety disordersGustavo Kinrys, John J Worthington, Lisa Wygant, et al.Journal of Affective Disorders|October 30, 2016
L-Methylfolate For Bipolar I depressive episodes: An open trial proof-of-concept registryAndrew A Nierenberg, Rebecca Montana, Gustavo Kinrys, et al.Cognitive Behaviour Therapy|February 15, 2019
Emotion regulation and motives for illicit drug use in opioid-dependent patientsAlexandra K Gold, Georgia Stathopoulou, Michael W OttoInternational Clinical Psychopharmacology|April 19, 2003
Valproic acid for the treatment of social anxiety disorderGustavo Kinrys, Mark H Pollack, Naomi M Simon, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 15, 2009
Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic reviewWilliam Berger, Mauro V Mendlowicz, Carla Marques-Portella, et al.The Journal of Clinical Psychiatry|May 3, 2006
An open-label trial of risperidone augmentation for refractory anxiety disordersNaomi M Simon, Elizabeth A Hoge, Diana Fischmann, et al.Journal of Affective Disorders|February 19, 2021
Psychotic symptoms during bipolar depressive episodes and suicidal ideationMaya Kuperberg, Douglas Katz, Sophie L A Greenebaum, et al.The Journal of Clinical Psychiatry|September 16, 2004
An open-label study of levetiracetam for the treatment of social anxiety disorderNaomi M Simon, John J Worthington, Alicia C Doyle, et al.Biological Psychiatry|September 6, 2005
Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled studyMark H Pollack, Naomi M Simon, Alyson K Zalta, et al.Psychopharmacology Bulletin|May 8, 2004
Bupropion sustained release for panic disorderNaomi M Simon, Naresh Emmanuel, James Ballenger, et al.Pageof 8